Cargando…

Clinical significance of serum PSA in breast cancer patients

BACKGROUND: Recent preclinical data suggest that androgen receptor (AR) signaling plays a significant role in subsets of breast cancer. Clinical trials testing AR-targeting therapies in breast cancer have been conducted. Assessment of AR-signal in breast cancer tissue maybe useful for treatment sele...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanamura, Toru, Ohno, Koichi, Hokibara, Shinya, Murasawa, Hideki, Nakamura, Toshitsugu, Watanabe, Hidehiko, Kaizuka, Machiko, Sawano, Shinji, Koyama, Hiroshi, Ito, Ken-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819570/ https://www.ncbi.nlm.nih.gov/pubmed/31664946 http://dx.doi.org/10.1186/s12885-019-6256-2

Ejemplares similares

Sebaceous carcinoma of the breast predominantly characterized by intraductal growth: a case report
por: Ohno, Koichi, et al.
Publicado: (2020)

Rapid tumor necrosis and massive hemorrhage induced by bevacizumab and paclitaxel combination therapy in a case of advanced breast cancer
por: Ono, Mayu, et al.
Publicado: (2013)

Human 3β‐hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations
por: Hanamura, Toru, et al.
Publicado: (2016)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
por: Yoneyama, Tohru, et al.
Publicado: (2021)

Prognostic significance of endothelial dysfunction in patients undergoing percutaneous coronary intervention in the era of drug-eluting stents
por: Kubo, Motoki, et al.
Publicado: (2015)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Epidermal growth factor receptor activation confers resistance to lenvatinib in thyroid cancer cells
por: Ohno, Koichi, et al.
Publicado: (2022)

A Neural Network Model Combining [-2]proPSA, freePSA, Total PSA, Cathepsin D, and Thrombospondin-1 Showed Increased Accuracy in the Identification of Clinically Significant Prostate Cancer
por: Gentile, Francesco, et al.
Publicado: (2023)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Seminal citrate is superior to PSA for detecting clinically significant prostate cancer
por: Gregório, Emerson Pereira, et al.
Publicado: (2019)

Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review
por: Oba, Takaaki, et al.
Publicado: (2016)

Impact of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome during Intensive Care Admission on Each Post-Intensive Care Syndrome Component in a PICS Clinic
por: Suganuma, Shinya, et al.
Publicado: (2023)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

OA12 Dactylitis in PsA: aetiology, clinical significance, & treatment implications
por: Melville, Andrew
Publicado: (2022)

Sebaceous carcinoma of the breast: a case report
por: Yamamoto, Yuta, et al.
Publicado: (2017)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Breast metastases of gastric signet-ring cell carcinoma: a report of two cases and review of the literature
por: Iesato, Asumi, et al.
Publicado: (2014)

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance
por: Gohno, Tatsuyuki, et al.
Publicado: (2012)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Characteristics of PSA Bounce after Radiotherapy for Prostate Cancer: A Meta-Analysis
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)

Incidental detection of localized prostate cancer with low PSA by computed tomography scan: A report of two cases
por: Bilim, Vladimir, et al.
Publicado: (2022)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

The Significance of PSA/IGF-1 Ratio in Differentiating Benign Prostate Hyperplasia from Prostate Cancer
por: Koliakos, G., et al.
Publicado: (2000)

Significance of PSA Screening in Niigata, Japan: Survey of Actual Status of New Cases of Prostate Cancer
por: Saito, Toshihiro, et al.
Publicado: (2021)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Clinical Significance of Free-to-Total Prostate-Specific Antigen (PSA) Ratio in Advanced Prostate Cancer Patients with PSA Less than 0.1 ng/ml after Hormone Treatment
por: Kim, Dae Il, et al.
Publicado: (2012)

Lack of an Association between Neutrophil-to-Lymphocyte Ratio and PSA Failure of Prostate Cancer Patients Who Underwent Radical Prostatectomy
por: Maeda, Yoko, et al.
Publicado: (2016)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
por: McGagh, Dylan, et al.
Publicado: (2020)

PSA 1972 : proceedings of the 1972 biennial meeting philosophy of science association
Publicado: (1974)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

Effects of Euglena gracilis EOD-1 Ingestion on Salivary IgA Reactivity and Health-Related Quality of Life in Humans
por: Ishibashi, Ken-ichi, et al.
Publicado: (2019)

Generation of a transgenic mouse line for conditional expression of human IL-6
por: Mori, Taiki, et al.
Publicado: (2016)

Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
por: Tang, Qionghua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cjacds91reoqvtv2p20pmunn88